Vitamin D supplementation in patients with multiple sclerosis
- Conditions
- Relapsing remitting multiple sclerosisMedDRA version: 20.1Level: LLTClassification code 10064137Term: Progression of multiple sclerosisSystem Organ Class: 100000004852Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Registration Number
- EUCTR2017-004846-31-SI
- Lead Sponsor
- niversity medical centre Maribor
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 95
• Relapsing remitting MS
• Treatment with immunomodulatory drug
• Age 18-60 years and
• EDSS score less than 5.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 95
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
•Use of vitamin D supplements in the past 3 months
•Pregnancy, planing pregnancy or nursing
•Relapse of disease and corticosteroide use in past month
•Active inflammmation at the start of the study (flu, cystitis etc.)
•Renal disease
•Elevated levels od calcium or parathormone
•Hypersensitivity to vitamin D prepartions
•Switching of immunomodulatory drug in past 3 months
•Other autoimmune disease
•History of hyperparathyroidism, liver disease, tuberculosis, sarcoidosis or kidney stones
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method